HuGE Literature Finder
Records
1
-
7
ERCC1 rs11615 polymorphism and chemosensitivity to platinum drugs in patients with ovarian cancer: a systematic review and meta-analysis. Journal of ovarian research 2021 Jun 14 (1): 80. Zhang Yuqiang, Cao Sufen, Zhuang Chunyu, Chen Jiacheng, Chen Xiaojing, Sun Hong, Lin Shengying, Lin Baila |
ERCC1 expression and platinum chemosensitivity in patients with ovarian cancer: A meta-analysis. The International journal of biological markers 2020 10 35 (4): 12-19. Zhang Chunjie, Gao Shan, Hou Jingw |
Association of excision repair cross-complimentary group 1 gene polymorphisms with breast and ovarian cancer susceptibility. Journal of cellular biochemistry 2019 May . Yang Fan, Mu Xiyan, Bian Ce, Zhang Huan, Yi Tao, Zhao Xia, Lin Xiaoju |
Genetic variants as ovarian cancer first-line treatment hallmarks: A systematic review and meta-analysis. Cancer treatment reviews 2017 Dec 61 35-52. Assis Joana, Pereira Carina, Nogueira Augusto, Pereira Deolinda, Carreira Rafael, Medeiros R |
Association between the ERCC1 polymorphism and platinum-based chemotherapy effectiveness in ovarian cancer: a meta-analysis. BMC women's health 2017 Jun 17 (1): 43. Tang Ning, Lyu Dan, Zhang Yan, Liu Haipi |
Predicting the outcome of platinum-based chemotherapies in epithelial ovarian cancer using the 8092C/A polymorphism of ERCC1: a meta-analysis. Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 2014 Mar 19 (2): 128-34. Li Yan, Hu Pei, Cao Yu, Wang Gui-ying, Wang Na, Zhou Rong-mi |
Association of Rs11615 (C>T) in the excision repair cross-complementing group 1 gene with ovarian but not gynecological cancer susceptibility: a meta-analysis. Asian Pacific journal of cancer prevention : APJCP 2014 15 (15): 6071-4. Ma Yong-Jun, Feng Sheng-Chun, Hu Shao-Long, Zhuang Shun-Hong, Fu Guan-H |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 20, 2023
- Content source: